Precision medicine research at Karmanos comparing biomarker

A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and

Making Biomarkers Relevant to Healthcare Innovation and Precision

PDF) Clinical Advances in Molecular Biomarkers for Cancer

Karmanos Cancer Institute and other top U.S. cancer centers call

Cancers, Free Full-Text

Frontiers Precision Medicine and the Role of Biomarkers of

Lasting bond and exceptional care through genetic counseling leads to rekindled friendship decades later

Cancer Epigenetics For Precision Medicine: Methods and Protocols

Jailan Elayoubi, M.D. Karmanos Physician Directory

Frontiers Biomarker-driven drug repurposing on biologically

Biomarkers and Precision Medicine in Oncology Practice and

IN THE NEWS: Sk8 to Eliminate Cancer Ice Show Detroit 2022